HIGHLIGHTS
- who: Jian Ding et al. from the University of Erlangen Nuremberg, Germany have published the Article: Pan-Cancer Analysis of the Oncogenic and Immunological Role of RCN3: A Potential Biomarker for Prognosis and Immunotherapy, in the Journal: (JOURNAL)
- how: Collectively these results indicated that RCN3 has an elevated expression in most cancers. The Kaplan-Meier analysis results indicated that higher expression of RCN3 was related to poor prognosis of OS in COAD READ MESO LIHC LGG and KIRC . The results showed that RCN3 expression level was negatively correlated with the level of immune infiltration of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.